Dragons' Den Competition at ISTH 2024
June 24 at 12PM in Ballroom B2
Stay tuned for the results in late July!Interested in Becoming a National VTE Research Network
Learn moreFostering International VTE Research Collaboration
INVENT-VTE seeks to improve the care of patients affected by venous thromboembolism (VTE) around the world through the design, development, conduct and promotion of high-quality clinical research into the causes, prevention, diagnosis and optimal management of VTE.
Endorsed Studies
TILE
Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
Sponsor:
Sunnybrook Health Sciences Centre
Toronto, Canada
Current Participant(s):
Canada, France,Status:
- Seeking sites and collaborators
Lead Network:
CanVECTORVERDICT
Venous thromboembolism in renally impaired patients and direct oral anticoagulants
Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Saint Etienne, France
Current Participant(s):
Canada, France, Serbia, Spain, Switzerland,Status:
- Seeking sites and collaborators
Lead Network:
INNOVTERENOVE
REduced dose versus full-dose of direct oral anticoagulant after uNprOvoked Venous thromboEmbolism. The RENOVE open-label, randomized, controlled trial
Sponsor:
Brest University Hospital
Brest, France
Current Participant(s):
France,Status:
- Recruitment to stop on June 30, 2022
Lead Network:
INNOVTESAVER
Statins for Venous Event Reduction in Patients with Venous Thromboembolism
Sponsor:
Ottawa Hospital Research Institute
Current Participant(s):
Canada,Status:
- Pilot trial recruitment completed in Canada and Norway
- Recruiting
- Seeking sites & collaborators
Lead Network:
CanVECTORPEITHO-III
A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism
Sponsor:
Hopital Européen Georges Pompidou, Assistance Publique Hopitaux de Paris, Université Paris Descartes
Current Participant(s):
Belgium, Canada, France, Germany, Italy, Poland, Romania, Spain, The Netherlands,Status:
- Recruiting
- Seeking sites and collaborators
Lead Network:
INNOVTEPilot PARTUM
Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Sponsor:
University of Calgary
Current Participant(s):
Canada, France, Ireland, The Netherlands,Status:
- Recruiting
- Seeking sites & collaborators
Lead Network:
CanVECTORADJUST-DVT
Age-adjusted d-dimer cutoff levels to rule out deep vein thrombosis
Sponsor:
University Hospital
Geneva, Switzerland
Current Participant(s):
Canada, Switzerland,Status:
- Recruiting
- Seeking sites & collaborators
Lead Network:
INNOVTEREDUCE
Management of recurrent venous thromboembolism during anticoagulant treatment in cancer patients - a prospective cohort study
Sponsor:
Amsterdam University Medical Center
Amsterdam, the Netherlands
Current Participant(s):
Italy, Spain, Switzerland, The Netherlands,Status:
- Recruiting
- Seeking sites & collaborators
Lead Network:
DTNRhea
Optimizing diagnosis of splanchnic vein thrombosis with MR direct thrombus imaging
Sponsor:
- The Netherlands: Dutch Thrombosis Network (Leiden University Medical Center, Leiden; Erasmus Medisch Centrum, Rotterdam)
- Italy: Thrombosis Research Italian Partnership (Varese University Hospital, Varese)
Current Participant(s):
Italy, The Netherlands,Lead Network:
DTNCOBRRA
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism
Sponsor:
OHRI (Ottawa Hospital Research Institute)
Current Participant(s):
Australia & New Zealand, Canada,Status:
- Recruiting
- Seeking sites & Collaborators
Lead Network:
CanVECTORSAFE-SSPE
Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: a multicenter randomized placebo-controlled non-inferiority trial
Sponsor:
Inselspital, Bern University Hospital, University of Bern
Current Participant(s):
Canada, Switzerland, The Netherlands,Status:
Recruiting
Lead Network:
DTNMEDEA
Heavy MEnstrual bleeding in premenopausal women treated with DirEct oral Anticoagulants
Sponsor:
Amsterdam University Medical Center
Current Participant(s):
Ireland, The Netherlands,Status:
Recruiting
Lead Network:
DTNDeterminants and Impact of the Post- Venous Thromboembolism (VTE) Syndromes
Determinants and Impact of the Post- Venous Thromboembolism (VTE) Syndromes
Sponsor:
Leiden University Medical Center, Leiden, The Netherlands.
Current Participant(s):
Canada, Ireland, The Netherlands,Lead Network:
DTNLEaD
Safely Ruling out Deep Vein Thrombosis in Pregnancy with the LEFt Clinical Decision Rule and D-dimer
Sponsor:
- Ottawa Hospital Research Institute
Current Participant(s):
Canada, Switzerland, The Netherlands,Status:
- Recruiting
Lead Network:
CanVECTORReal-World Use of DOACs in Children: An International Registry
Real-World Use of DOACs in Children: An International Registry
Sponsor:
- Children’s Hospital of Philadelphia
- University of Amsterdam
Current Participant(s):
The Netherlands, USA,Lead Network:
VENUSDAYS
A pilot study to assess feasibility of evaluating the safety and efficiency of a simplified diagnostic approach for deep vein thrombosis
Sponsor:
Queen’s University
Current Participant(s):
Canada, The Netherlands,Status:
Recruitment has not started.
Lead Network:
CanVECTORAPI-CALF
Apixaban to treat calf vein thrombosis
Sponsor:
Sunnybrook Research Institute, University of Toronto
Current Participant(s):
Canada, France,Status:
Recruitment has not started.
Lead Network:
CanVECTORHYDRA
Safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography alone for suspected pulmonary embolism in patients with malignancy
Sponsor:
Leiden University Medical Center
Current Participant(s):
Belgium, France, Spain, Switzerland, The Netherlands,Status:
- Recruiting
- Seeking sites & Collaborators
Lead Network:
DTNPREP and GO
A prospective cohort study evaluating peripartum anticoagulation management among pregnant women with VTE and its impact on patient outcomes
Sponsor:
University of Calgary
Current Participant(s):
France, Ireland, The Netherlands, USA,Status:
- Recruiting
- Seeking sites & collaborators
Lead Network:
CanVECTORSPECTACULAR
Comparison of 3 Diagnostic Strategies of PE: Planar V/Q Scan, CTPA, and V/Q SPECT
Sponsor:
Brest University Hospital
Brest, France
Current Participant(s):
Canada, France, Switzerland,Status:
- Recruiting
- Seeking sites & collaborators
Lead Network:
INNOVTEDose-Adjusted Apixaban
A Clinical Trial of Dose-Adjusted Apixaban In CancerPatients with Thrombocytopenia and Venous Thromboembolism
Sponsor:
Beth Israel Deaconess Medical Center, USA
Current Participant(s):
The Netherlands, USA,Lead Network:
VENUSCONQUER-DVT Pilot
Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis
Sponsor:
Gabriele d'Annunzio University, Italy
University of Ottawa; Ottawa Hospital Research Institute, Canada
Current Participant(s):
Canada, Italy,Status:
Recruiting
Lead Network:
TRIPHYPATIA
A Prospective Randomised Controlled Trial of Hydroxychloroquine Versus Placebo during Pregnancy in Women with Antiphospholipid Antibodies
Sponsor:
Rigshospitalet, Denmark (EU sites)
Guy’s and St Thomas’, UK ( UK and Canadian sites)
Current Participant(s):
Canada, Denmark, United Kingdom,Status:
Recruiting
Lead Network:
CanVECTORBAT-VTE
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
Sponsor:
Current Participant(s):
Canada, France,Status:
Recruiting
Lead Network:
INNOVTEPROSPECT
Sponsor:
International Pediatric Thrombosis Network
Current Participant(s):
The Netherlands,Lead Network:
VENUSSubscribe